Camp4 Therapeutics Corporation
CAMP
$2.05
$0.063.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.86% | -- | -- | -84.85% | |
| Total Receivables | -75.57% | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 157.06% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 57.59% | -- | -- | -- | |
| Total Current Assets | 65.90% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 65.90% | -- | -- | -- | |
| Net Property, Plant & Equipment | -22.61% | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 0.00% | -- | -- | -- | |
| Total Assets | 42.52% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | 16.12% | -- | -- | -- | |
| Total Accrued Expenses | 42.58% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -8.46% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 219.03% | -- | -- | -- | |
| Total Other Current Liabilities | 219.03% | -- | -- | -- | |
| Total Current Liabilities | 22.94% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | 22.94% | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -35.58% | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 0.00% | -- | -- | -- | |
| Total Liabilities | -8.26% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 658.71% | -- | -- | -- | |
| Retained Earnings | -32.38% | -- | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 151.03% | -- | -- | -89.75% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 0.00% | |
|
|
|||||
| Total Common Equity | 151.03% | -- | -- | -89.75% | |
| Total Preferred Equity | -- | -- | -- | 0.00% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 64.36% | -- | -- | -82.23% | |
|
|
|||||